8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  June 24, 2024

PetMed Express, Inc.

(Exact name of registrant as specified in its charter)

Florida	000-28827	65-0680967
(State or other jurisdiction<br><br>of incorporation)	(Commission<br><br>File Number)	(I.R.S. Employer<br><br>Identification No.)

420 South Congress Avenue, Delray Beach, Florida 33445

(Address of principal executive offices) (Zip Code)

(561) 526-4444

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $.001 per share	PETS	NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. o

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Director

On June 20, 2024, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved the appointment of Leah A. Solivan to serve as a director of the Company beginning June 24, 2024. Ms. Solivan will hold this position until the 2024 annual meeting of the Company’s shareholders or until her successor is elected and qualified, subject to her earlier resignation or removal. Ms. Solivan will also serve on the Board’s Compensation and Human Capital Committee and Corporate Governance and Nominating Committee. In connection with her appointment to the Board, Ms. Solivan will receive compensation in accordance with the Company’s Non-Employee Director Compensation Program.

Leah Solivan, age 44, is currently a Managing Director at Fuel Capital L.P., a seed stage venture capital firm investing in consumer, software as a service (SaaS) and infrastructure companies, where she manages three high performing funds, with over seven unicorn companies across the portfolio. Ms. Solivan has served at Fuel Capital since July 2017.

Ms. Solivan began her career as a software engineer at IBM and subsequently founded TaskRabbit, Inc. (“TaskRabbit”), a pioneering on-demand marketplace company in 2008. As TaskRabbit’s CEO for eight years, Ms. Solivan raised more than $50 million in venture capital and scaled the company into an international business with operations in 44 cities. In 2017, she oversaw TaskRabbit’s successful sale to Inter IKEA Systems B.V.

Additionally, Ms. Solivan has taken an active role in the Young Presidents’ Organization (“YPO”), a worldwide leadership community of chief executives. A member since 2014, she was awarded the Alexander Capello Award, the highest honor in membership, for her work in promoting gender equity. In 2023 she became Chair of the Regional Board, Pacific US; she also serves on a global committee for the YPO International Board. Ms. Solivan has been recognized by the World Economic Forum as a Young Global Leader. She has served as an advisor to children’s apparel brand Monica + Andy since July of 2017 and as a venture advisor to Screendoor Partners since January 2021.

Ms. Solivan has been a frequent speaker at events such as the World Economic Forum in Davos, Switzerland and Tina Brown’s Women in the World Summit. Her achievements have been featured in publications, including the Wall Street Journal, Wired, and Time, and Fast Company named her one of the “100 Most Creative People in Business.” She is a regular contributor to Fast Company and has appeared on MSNBC and Bloomberg — among other broadcasts.

Ms. Solivan earned a B.S. in Mathematics and Computer Science from Sweet Briar College, where she also served on the Board of Directors from July 2015 until August 2018.

There are no family relationships between Ms. Solivan and any other executive officers or directors of the Company. There is no arrangement or understanding between Ms. Solivan and any other persons pursuant to which she was selected as director. There are no transactions to which the Company is a party and in which Ms. Solivan has a material interest that is required to be disclosed under Item 404(a) of Regulation S-K.

Ms. Solivan and the Company will enter into the Company’s standard form of director indemnification agreement, whereby the Company agrees to indemnify, defend and hold its directors harmless from and against losses and expenses incurred as a result of their Board service, subject to the terms and conditions provided in the agreement. The form of indemnification agreement is filed as Exhibit 10.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, filed with the Securities and Exchange Commission on June 14, 2024.

Item 7.01 Regulation FD Disclosure

On June 24, 2024, the Company issued a press release announcing the appointment of Ms. Solivan as a member of the Board. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information in this Item 7.01 and the related information in Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act or the Exchange Act except as set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.	Description
99.1	Press Release datedJune24, 2024.
104	Cover Page Interactive Data File (formatted as Inline XBRL)

* * *

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 24, 2024

PETMED EXPRESS, INC.
By:	/s/ Christine Chambers
Name:	Christine Chambers
Title:	Chief Financial Officer, Treasurer and Secretary

4

Document

EXHIBIT 99.1

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

Visionary founder and investor brings decades of experience building and scaling digital consumer brands

DELRAY BEACH, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company") today announced the appointment of Leah Solivan to the Company’s Board of Directors (“the Board”), effective June 24, 2024. Solivan brings over 20 years of experience building and scaling technology businesses to the Company’s Board. As a General Partner at Fuel Capital, she focuses on early-stage investments across a variety of sectors, including consumer technology, hardware, education, marketplaces, and retail. Her entrepreneurial acumen is exemplified by her founding of TaskRabbit in 2008, which she steered through significant growth phases before orchestrating its successful acquisition by IKEA in 2017.

“Leah’s strong digital background and proven track record of scaling technology-driven businesses from startups to billion-dollar enterprises will make her an invaluable advisor and member of our Board. Leah has demonstrated a remarkable ability to launch and grow consumer brands that deeply resonate with their target audiences. Her insights and experience will be instrumental in helping guide our strategic direction and accelerating our growth trajectory,” said Leslie C. G. Campbell, Chairman of the Board. “We are delighted to welcome her to the Board during this transformational period for the Company.”

Sandra Campos, President and CEO, commented, “We are ecstatic to welcome Leah to our Board. Her diverse experience as a consumer-centric, entrepreneurial visionary will be invaluable to our growth. Leah's strategic insight and technology acumen, combined with her passion for pets—including her beloved Maine Coon cat and equestrian pursuits—align perfectly with our commitment to providing exceptional preventive and wellness products for dogs, cats, and horses.”

“I’m excited to join the Board at this pivotal moment in the company’s journey,” said Ms. Solivan. “As the company continues to enhance its technological capabilities and deepen its understanding of consumer needs, we have a tremendous opportunity to expand our position as a trusted go-to leader in our industry. My experience as a pet owner fuels my dedication to our purpose and I’m eager to collaborate with my fellow Board members to drive growth, expand our market presence, and create lasting value for all stakeholders.”

About Leah Solivan

Ms. Solivan is currently a General Partner at Fuel Capital, a seed stage venture capital firm investing in consumer, software as a service (SaaS) and infrastructure companies. Ms. Solivan has served at Fuel Capital since July 2017.

Before Fuel Capital, Ms. Solivan created one of the most widely recognized new consumer technology brands of the past decades with TaskRabbit, the pioneering on-demand marketplace company she founded in 2008. As TaskRabbit’s CEO for eight years, Leah scaled the company into an international business with operations in 44 cities and more than $50 million in venture capital funding. In 2017, Ms. Solivan oversaw TaskRabbit’s successful sale to IKEA, the multinational home decor corporation.

Ms. Solivan began her career as a software engineer at IBM, where she worked for seven years on products including Lotus Notes and Domino.

With over twenty years of experience, Ms. Solivan is a frequent speaker on topics such as entrepreneurship, the future of work, and women in technology. Ms. Solivan’s achievements have been featured in publications including the Wall Street Journal, Wired, and Time, and Fast Company named her one of the “100 Most Creative People in Business.” Ms. Solivan holds a Bachelor of Science degree in Mathematics and Computer Science from Sweet Briar College, where she has served on the Board of Directors.

About PetMed Express, Inc.

Founded in 1996, PetMeds is a leader in the digital pet pharmacy industry. As a national online retailer, PetMeds.com and PetCareRx.com are top choices for delivering preventive and chronic symptom prescriptions and OTC medications and products through their thousands of veterinary partners and a loyal customer base. Leveraging telehealth and insurance partnerships, they offer unparalleled value and convenience to pet parents at every stage of their pets' lives, whether dogs, cats, or horses. PetMeds and PetCareRx provide a comprehensive range of medications, food products, and essential supplies through their websites, www.PetMeds.com and www.PetCareRx.com.

Forward Looking Statement

This press release may contain “forward-looking statements”, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such forward-looking statements are set forth in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in the Company’s Annual Report on Form 10-K for the year ended March 31, 2024. The Company’s future results may also be impacted by other risk factors listed from time to time in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and periodic filings on Form 8-K. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release and should not be relied upon as representing the Company’s views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements, other than as may be required by law. If the Company does update one or more forward-looking statements, no inference should be made that the Company will make additional updates with respect to those or other forward-looking statements.

Investor Contact:

ICR, LLC

John Mills

(646) 277-1254

Reed Anderson

(646) 277-1260

investor@petmeds.com